CODOX-M/IVAC regimen

Jump to navigation Jump to search

WikiDoc Resources for CODOX-M/IVAC regimen

Articles

Most recent articles on CODOX-M/IVAC regimen

Most cited articles on CODOX-M/IVAC regimen

Review articles on CODOX-M/IVAC regimen

Articles on CODOX-M/IVAC regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CODOX-M/IVAC regimen

Images of CODOX-M/IVAC regimen

Photos of CODOX-M/IVAC regimen

Podcasts & MP3s on CODOX-M/IVAC regimen

Videos on CODOX-M/IVAC regimen

Evidence Based Medicine

Cochrane Collaboration on CODOX-M/IVAC regimen

Bandolier on CODOX-M/IVAC regimen

TRIP on CODOX-M/IVAC regimen

Clinical Trials

Ongoing Trials on CODOX-M/IVAC regimen at Clinical Trials.gov

Trial results on CODOX-M/IVAC regimen

Clinical Trials on CODOX-M/IVAC regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CODOX-M/IVAC regimen

NICE Guidance on CODOX-M/IVAC regimen

NHS PRODIGY Guidance

FDA on CODOX-M/IVAC regimen

CDC on CODOX-M/IVAC regimen

Books

Books on CODOX-M/IVAC regimen

News

CODOX-M/IVAC regimen in the news

Be alerted to news on CODOX-M/IVAC regimen

News trends on CODOX-M/IVAC regimen

Commentary

Blogs on CODOX-M/IVAC regimen

Definitions

Definitions of CODOX-M/IVAC regimen

Patient Resources / Community

Patient resources on CODOX-M/IVAC regimen

Discussion groups on CODOX-M/IVAC regimen

Patient Handouts on CODOX-M/IVAC regimen

Directions to Hospitals Treating CODOX-M/IVAC regimen

Risk calculators and risk factors for CODOX-M/IVAC regimen

Healthcare Provider Resources

Symptoms of CODOX-M/IVAC regimen

Causes & Risk Factors for CODOX-M/IVAC regimen

Diagnostic studies for CODOX-M/IVAC regimen

Treatment of CODOX-M/IVAC regimen

Continuing Medical Education (CME)

CME Programs on CODOX-M/IVAC regimen

International

CODOX-M/IVAC regimen en Espanol

CODOX-M/IVAC regimen en Francais

Business

CODOX-M/IVAC regimen in the Marketplace

Patents on CODOX-M/IVAC regimen

Experimental / Informatics

List of terms related to CODOX-M/IVAC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:CODOX-M/IVAC Regimen; Cyclophosphamide-Oncovin-Doxorubicin-Methotrexate/Ifosfamide, VePesid, AraC Regimen; McGrath Regimen

Overview

CODOX-M/IVAC regimen refers to a regimen consisting of cyclophosphamide, vincristine, doxorubicin and high-dose methotrexate (CODOX-M) alternating with ifosfamide, etoposide and high-dose cytarabine (IVAC), used as a treatment for aggressive forms of non-Hodgkin's lymphoma; also used as primary treatment for AIDS-related and high-risk Burkitt's lymphoma. Intrathecal cytarabine and methotrexate are included in this regimen as either prophylaxis or treatment for central nervous system (CNS) involvement.[1]

Regimen

CCyclophosphamide

VVincristine

DOXDoxorubicin

MMethotrexate

IIfosfamide

VVepesid (etoposide)

ACAra-C (cytarabine)


Indications

References

  1. "NCI Thesaurus".
  2. "NCI Thesaurus".